Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2020New England Journal of MedicineOpen Access

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2020 study studied this question.

synapsesocial.com/papers/6a82d8869f5484a76e0f70abhttps://doi.org/10.1056/nejmoa2023184
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers2000 · 120 citations
  2. 2A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-192020 · 5,526 citations
  3. 3COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology2020 · 124 citations
  4. 4Lopinavir pharmacokinetics in COVID-19 patients2020 · 63 citations
  5. 5Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-192020 · 1,282 citations